SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-103423
Filing Date
2022-09-28
Accepted
2022-09-27 17:51:52
Documents
14
Period of Report
2022-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2226769d1_8k.htm   iXBRL 8-K 31842
2 EXHIBIT 2.1 tm2226769d1_ex2-1.htm EX-2.1 31561
3 EXHIBIT 99.1 tm2226769d1_ex99-1.htm EX-99.1 114657
  Complete submission text file 0001104659-22-103423.txt   367858

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20220926.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20220926_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20220926_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2226769d1_8k_htm.xml XML 3602
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 221272355
SIC: 2834 Pharmaceutical Preparations